Spread pricing

Spread pricing is the pharmacy benefit manager practice of charging a plan sponsor more for a prescription than the PBM pays the dispensing pharmacy, then keeping the difference as PBM revenue. The spread compounds across millions of generic claims and is often invisible to both the plan and the pharmacy. State PBM reform laws (Ohio single-PBM Medicaid contract 2019, California SB 41, Florida SB 1550, and over 25 others) target spread pricing through pass-through pricing requirements, disclosure mandates, and audit rights.

How spread pricing works

The plan sponsor pays the PBM a "billed amount" for each claim. The PBM pays the pharmacy a "reimbursed amount" through the network contract. The spread is the difference, retained by the PBM as revenue. The mechanic is most pronounced on generic drugs where the PBM controls the MAC list on the pharmacy side and the plan-side contract rate is set in negotiations the pharmacy does not see. On a $4 generic dispensing fee structure, the spread can be a few cents per claim. Across a Medicaid book of millions of claims a year, the cumulative spread runs into hundreds of millions of dollars, as multiple state Medicaid audits and the 2024 FTC interim report documented.

Pass-through pricing is the structural alternative: the plan pays the PBM exactly what the PBM pays the pharmacy plus a disclosed administrative fee. Pass-through removes the spread but does not remove all PBM economic levers (rebate aggregation, network steering, audit-driven recoupment).

When spread pricing applies

Spread pricing applies in any PBM contract structure that allows the PBM to retain the difference between billed and reimbursed amounts. Most commercial PBM contracts permit spread by default. Medicaid managed care contracts are increasingly mandating pass-through pricing as a condition of program participation, with Ohio, Kentucky, West Virginia, and over a dozen other states leading the shift. Medicare Part D has separate economic structures (DIR fees, rebate aggregation) that overlap with but are not identical to spread pricing.

The pharmacy's exposure under spread pricing

Pharmacies do not directly pay the spread but they bear its downstream consequences. Spread pricing creates structural pressure on PBMs to compress pharmacy reimbursement, since every dollar of MAC reduction at the pharmacy end is a dollar of spread retained at the plan end. Audit pressure follows the same logic: post-payment recoupment converts dispensed claims into PBM revenue without affecting the plan's billed amount. The defense framework focuses on state PBM transparency laws, audit-finding challenges that surface spread-driven recoupment patterns, and contractual reconciliation rights where the network contract guarantees an effective reimbursement rate.

Related terms

• MAC pricing The reimbursement ceiling on generics that PBMs control directly, the lever through which spread pricing operates on the pharmacy side.
• DIR fees Medicare Part D performance-based fees that interact with but are distinct from commercial spread pricing.
• Effective rate guarantee The contractual mechanism some pharmacies use to recover lost margin across the generic book.
• Provider manual The PBM document that sets the operational rules pharmacy must follow within the contracted reimbursement structure.

See also

• Practice area
  PBM Audit Defense

  The full PBM audit defense framework, including challenges to recoupment patterns that surface spread-driven economic motives.

• Practice area
  Express Scripts Audit Defense

  Express Scripts-specific defense framework, including the post-FTC settlement landscape and the CoverMyMeds account-level enforcement wave.